PCOS Long Term Risks: Diabetes, Heart, Sleep Apnea and Cancer
What PCOS can mean for your health over the decades: the metabolic risks, the screening your clinician can offer, and the warning signs that need prompt care.

On this page
- What are the PCOS long term risks for your body?
- How does PCOS raise the risk of type 2 diabetes?
- Does PCOS increase the risk of heart disease and stroke?
- Does PCOS raise the risk of sleep apnea?
- Why does PCOS raise the risk of endometrial cancer?
- What else should you watch for over time?
- Do treatments lower these long term risks?
- How can you check for each long term risk?
- What steps can you take now?
- What the research says
- When to see a doctor
- Regional notes
- Frequently asked questions
- The bottom line
PCOS long term risks are mostly metabolic. Women with polycystic ovary syndrome (PCOS) have a higher chance of developing type 2 diabetes, high blood pressure, unhealthy blood fats and, over time, heart and blood vessel disease. PCOS is also linked to obstructive sleep apnea, and to endometrial (uterine lining) changes when ovulation is rare. Early checks and a plan with your clinician can lower many of these risks.
Cardiometabolic risk: the combined chance of developing type 2 diabetes, high blood pressure, abnormal blood fats and heart or blood vessel disease. In many people with PCOS, these risks are linked to insulin resistance.
Key takeaways
- The World Health Organization estimates that PCOS affects 10–13% of women of reproductive age, and that up to 70% of affected women are undiagnosed, so many long term risks are never checked (WHO PCOS fact sheet).
- The U.S. Centers for Disease Control and Prevention (CDC) describes PCOS as associated with a higher risk of type 2 diabetes, which is why blood sugar checks belong in PCOS care (CDC, PCOS and diabetes).
- The International Evidence-based PCOS Guideline (2023) recommends checking blood sugar and blood fats at diagnosis and blood pressure every year, with blood sugar reassessed every one to three years (Monash University guideline).
- The 2023 guideline states that obstructive sleep apnea is significantly more common in people with PCOS, independent of body weight, so it is worth mentioning snoring and daytime tiredness to your clinician (Monash University guideline).
- When ovulation is infrequent, the uterine lining can thicken without being shed regularly, and the 2023 guideline states that premenopausal women with PCOS have a markedly higher risk of endometrial hyperplasia and endometrial cancer (Teede et al., Human Reproduction, 2023).
- A 2026 Lancet consensus proposes renaming PCOS to polyendocrine metabolic ovarian syndrome (PMOS), with a three-year transition (Teede et al., The Lancet, 2026).
What are the PCOS long term risks for your body?
PCOS is usually described by what shows up in your cycle and on your skin: irregular periods, signs of high androgens such as acne and extra hair growth, and sometimes ovaries that look "polycystic" on ultrasound. Its long term risks come mostly from metabolism, which is the way the body handles blood sugar, fat and blood pressure. Many people with PCOS have insulin resistance, a state in which cells respond less well to insulin. The pancreas then makes more insulin to keep blood sugar in range. Over years, that extra insulin and the changes that come with it can push some people toward diabetes and cardiovascular disease. Our guide to PCOS insulin resistance explains this mechanism in more detail.
The main long term risks fall into four groups. The first is type 2 diabetes and prediabetes. The second is cardiovascular disease, which includes heart attack and stroke, along with the high blood pressure and abnormal cholesterol that raise their risk. The third is obstructive sleep apnea, a breathing disorder during sleep. The fourth is endometrial hyperplasia and endometrial cancer, which relate to long periods without a regular shed of the uterine lining. Depression and anxiety are also more common in PCOS, and they deserve the same attention. For how the condition is diagnosed in the first place, see our PCOS symptoms and diagnosis guide.
Not everyone with PCOS faces every risk. Body weight, family history, age, ethnicity, smoking and how long metabolic changes have been present all shape the picture. A normal body weight does not rule out insulin resistance, so a lean person with PCOS can still benefit from metabolic checks. A tracker such as Shebalance can keep your symptom and cycle record in one place, so the pattern is easier to see when you talk with your clinician.
Why does PCOS reach beyond the ovaries?
PCOS is best understood as a condition that affects several hormone systems at once. High insulin can stimulate the ovaries to make more androgens, which in turn can disrupt ovulation. High insulin can also lower sex hormone-binding globulin (SHBG), the protein that carries sex hormones in the blood, so more active androgen circulates. These feedback loops explain why one person can have irregular periods, skin changes and blood sugar changes at the same time. They also explain why treating one feature, such as cycles, does not always improve the others.
What does the 2026 name change mean for long term care?
In 2026, a global consensus published in The Lancet proposed renaming PCOS to polyendocrine metabolic ovarian syndrome (PMOS). The authors, Teede HJ and colleagues, describe a three-year transition, and they say integration into international guidelines is planned for upcoming updates. The new name points toward the hormone and metabolic picture that drives the risks in this article. It does not change your risks, and it does not change which checks are available today. Our explainer on PCOS becoming PMOS covers what the new name means for diagnosis and treatment.
How does PCOS raise the risk of type 2 diabetes?
Type 2 diabetes is the long term risk most consistently linked to PCOS. The CDC's guidance on PCOS and diabetes explains that women with PCOS have a higher risk of developing type 2 diabetes than women without it, and that insulin resistance is a central part of that link (CDC, PCOS and diabetes). Because the link runs through insulin, blood sugar is one of the first things a clinician checks.
When cells do not respond well to insulin, the pancreas makes more of it. For a time, blood sugar stays close to normal. Over the years, the pancreas may struggle to keep up, and blood sugar rises into the prediabetes range and then into diabetes. This process is usually gradual and often silent. Many people find out only during a routine blood test, a pregnancy check or a visit for another concern, which is why asking directly about blood sugar matters.
Which blood sugar tests does a clinician use?
The International Evidence-based PCOS Guideline 2023 recommends that blood sugar be assessed at diagnosis in all adults and adolescents with PCOS, and reassessed every one to three years depending on other risk factors (Monash University guideline). The guideline names the 75 g oral glucose tolerance test as the most accurate test in PCOS. In practice, clinicians use a fasting glucose test, an oral glucose tolerance test (OGTT) that measures blood sugar before and two hours after a sweet drink, or an HbA1c test, which reflects average blood sugar over roughly three months. Fasting glucose or HbA1c can be used when an OGTT is not practical, but they are less accurate. An OGTT can reveal abnormal blood sugar that a single fasting reading misses. Ask which test is being used and why, and ask how the result will be repeated if it is borderline.
A single abnormal result is usually confirmed before a diagnosis is made, so an unclear result is a reason to plan a follow-up, not a reason to worry alone. Keep a note of the date, the test and the value, and bring it to your next visit.
What lowers the chance of diabetes progressing?
Lifestyle changes are the foundation of care for insulin resistance in PCOS. Regular physical activity, a diet built around vegetables, legumes, whole grains and lean proteins, and gradual weight loss where it is relevant to your health can all improve how the body handles insulin. Medicines are an option for some people, and they are chosen with a clinician. Metformin and inositol are two options that are discussed for PCOS, and the evidence for each varies, so it is worth asking your clinician what fits your history.
Does PCOS increase the risk of heart disease and stroke?
Heart disease is one of the leading causes of death for women. Blood pressure, cholesterol and blood sugar are three of the four health factors, alongside body weight, in the American Heart Association's Life's Essential 8 measures of heart health (American Heart Association, Life's Essential 8). PCOS touches all three. Several markers that raise heart risk are more common in PCOS, including higher triglycerides, lower HDL ("good") cholesterol and, in some groups, higher blood pressure.
Evidence is strongest for these metabolic markers. Studies have found them more often in people with PCOS than in comparison groups, and the 2023 guideline states that women with PCOS should be considered at increased risk of cardiovascular disease and assessed for its risk factors. The evidence for actual heart attacks and strokes is less settled. Some large studies have reported higher rates, but findings vary with age, body weight and how PCOS was defined in each study. The honest reading is that the risk signal is real, while its size differs from person to person.
What do blood fats and blood pressure tell you?
Blood fats are measured with a lipid panel, which reports total cholesterol, LDL ("bad") cholesterol, HDL ("good") cholesterol and triglycerides. Blood pressure is measured at rest, and readings that stay above target across several visits are the ones that matter most. The 2023 guideline recommends a lipid profile at diagnosis for all women with PCOS, whatever their age or weight, and a blood pressure check every year and when planning pregnancy. Neither test is painful, and both can reveal risk long before symptoms appear. Your clinician can then decide with you whether lifestyle changes, medicine or both are the right next step. Medicines for blood pressure or cholesterol should never be started, stopped or changed without your clinician.
Is the heart link proven?
It helps to think of the evidence in layers. The link between PCOS and abnormal blood fats and blood pressure is well supported, which is strong evidence for the markers. The link to heart attacks and strokes is supported by cohort studies, but the results are less consistent, so the evidence there is limited to moderate. Long-term outcome studies designed specifically for PCOS are still limited. The practical response is the same whichever layer you read: measure the markers, track them over time and act on them with your clinician.
Try it
Logging symptoms for a few weeks gives your clinician a clearer picture of your pattern than a single visit can, and the free Android app Shebalance can turn that log into a doctor-ready PDF. Open Shebalance
Does PCOS raise the risk of sleep apnea?
Obstructive sleep apnea is a condition in which the airway repeatedly narrows or closes during sleep. The result is breathing pauses, fragmented sleep and, often, loud snoring. The International Evidence-based PCOS Guideline 2023 states that obstructive sleep apnea is significantly more common in women with PCOS, independent of body weight, and recommends asking about its symptoms, with a formal sleep study needed to confirm it (Monash University guideline). Excess weight raises the risk further. The two conditions can reinforce each other, because poor sleep can worsen insulin resistance and blood pressure, and extra weight can worsen breathing during sleep.
What are the warning signs of sleep apnea?
Common signs include loud and frequent snoring, breathing pauses that a partner notices, waking with a dry mouth or headache, feeling unrefreshed after a full night in bed, and sleepiness during the day. If several of these happen, tell your clinician, even if you think they are normal for you. A sleep study is the usual way to confirm sleep apnea, and some people can complete a home version of the test, depending on local services.
How is sleep apnea treated?
Treatment depends on how severe the apnea is and on your clinician's assessment. Options include weight and lifestyle changes, changes to sleep position, and a breathing device called CPAP (continuous positive airway pressure). Ask your clinician which option fits you. Avoid using sleeping pills or alcohol to force sleep without checking first, because both can make breathing during sleep worse.
Why does PCOS raise the risk of endometrial cancer?
In a typical cycle, ovulation releases an egg and then progesterone rises. Progesterone matures the uterine lining, called the endometrium, and the lining is shed as a period. When ovulation is rare or absent, progesterone is not made in the usual way, so the lining is exposed to estrogen for long stretches without that balance. This unopposed estrogen can cause the lining to thicken, a condition called endometrial hyperplasia. The 2023 international guideline states that premenopausal women with PCOS have a markedly higher risk of endometrial hyperplasia and endometrial cancer, although the absolute risk stays low for most (Teede et al., Human Reproduction, 2023).
Endometrial hyperplasia can progress to endometrial cancer in some cases, which is why clinicians take persistent abnormal bleeding seriously. Not every thickened lining becomes cancer. The guideline does not recommend routine screening of the lining, but it supports prevention through weight management, cycle regulation and regular progestogen therapy, and a biopsy when the lining is unusually thick. Treatment, often with a progestogen, aims to restore a healthy lining, and the choice depends on the type of change found and on your personal history.
How do irregular cycles affect the risk?
The 2023 International Evidence-based PCOS Guideline defines irregular cycles in adults, more than three years after the first period, as cycles shorter than 21 days or longer than 35 days, or fewer than eight cycles a year (Monash University guideline). A pattern that falls outside this range is a good reason to discuss uterine lining checks with your clinician. Recording the dates of your periods, and any spotting between them, gives that conversation a clear starting point.
When is bleeding a warning sign?
Bleeding that is heavier than usual, lasts longer than usual, comes between periods, or happens after menopause needs prompt medical review. Bleeding after menopause always needs assessment, whatever the likely cause. Do not wait for your next routine visit if the bleeding is new or unusual for you. The urgent care box at the end of this article lists the other signs that need prompt attention.
What else should you watch for over time?
Long term health in PCOS is not only about the body's metabolism. Mood, pregnancy and other areas also need attention, and each is easier to manage when it is noticed early.
How do mood and anxiety fit in?
Depression and anxiety are more common in people with PCOS than in those without, and concerns about body image or disordered eating can appear too. The 2023 guideline recommends screening all adults with PCOS for depression and anxiety using validated questionnaires. If low mood, worry or changes in eating are affecting daily life, tell your clinician early, because treatment is effective and can be started alongside other care. Our guide to PCOS and mental health covers the options in detail. If you have thoughts of harming yourself, seek help straight away.
What about pregnancy?
Pregnancy is another point where metabolic risk shows. The 2023 guideline states that pregnant women with PCOS have a higher risk of gestational diabetes, high blood pressure in pregnancy and preeclampsia, and it recommends a blood pressure check and an OGTT when planning pregnancy, with an OGTT repeated at 24 to 28 weeks. If you use a GLP-1 medicine, the U.S. prescribing information for Wegovy advises stopping it at least two months before a planned pregnancy, so raise your plans with your clinician early.
Do treatments lower these long term risks?
Treatment cannot erase the risks, but it can change how far they progress. The core of care is lifestyle: regular physical activity, a balanced eating pattern, weight management where it is relevant to your health, and good sleep. Medicines can be added where they fit. The International Evidence-based PCOS Guideline 2023 lists anti-obesity medicines, including liraglutide and semaglutide, as options that could be considered alongside lifestyle changes (Monash University guideline).
What do GLP-1 medicines show so far?
Semaglutide, a GLP-1 medicine, has been studied in adults with overweight or obesity. In the STEP 1 trial, people on semaglutide lost about 15% of their body weight on average at 68 weeks, compared with about 2% on placebo (Wilding et al., New England Journal of Medicine, 2021). That trial did not study people with PCOS. Using GLP-1 medicines for PCOS is therefore off-label, and the evidence on whether they reduce long term PCOS risks is still developing. If you take a GLP-1 medicine and also use hormonal birth control, the U.S. prescribing information for Zepbound advises switching to a non-oral method, or adding a barrier method, for 4 weeks after starting and after each dose increase. Read our guide to GLP-1 medicines for PCOS for more detail, and never start, stop or switch a medicine without your clinician.
How can you check for each long term risk?
The table below pairs each long term risk with the check your clinician may consider and the strength of the evidence behind it. The strength labels are a summary of the evidence cited in this article, not a substitute for your clinician's judgment.
| Long term risk | What is checked | Why it matters | Evidence strength |
|---|---|---|---|
| Type 2 diabetes | Fasting glucose, OGTT or HbA1c, as your clinician chooses | Finding abnormal blood sugar early creates time to act | Strong for the link; screening is part of guideline care |
| High blood pressure and abnormal blood fats | Blood pressure readings and a lipid panel | These markers add to heart and blood vessel risk | Strong for the markers; event evidence is more limited |
| Obstructive sleep apnea | Symptom review, with a sleep study if signs are present | Untreated apnea disrupts sleep and can affect blood pressure | Higher prevalence is recognized in the guideline |
| Endometrial hyperplasia and cancer | Review of cycle and bleeding pattern; further assessment when bleeding is abnormal (routine screening is not recommended) | Changes in the lining are detectable and can be treated | Higher risk is recognized in the guideline; absolute risk is low for most |
| Depression and anxiety | Screening questionnaires, recommended for all adults with PCOS | Mental health treatment is effective and can start early | Recognized in the guideline, which recommends screening |
What steps can you take now?
Most of the work happens in routine care, and a few simple habits make it easier. Work through this list with your clinician at your next visit.
- Ask for a blood sugar test, and ask which test is being used and when it should be repeated.
- Have your blood pressure measured at routine visits, and ask whether a lipid panel is due.
- Record your cycles, including long gaps between periods, spotting and any unusual bleeding, and share the record with your clinician.
- Mention snoring, breathing pauses and daytime sleepiness, even if you think they are normal for you.
- Build regular movement into most days. Walking, and strength training on some days, both fit into most routines. Our guide to the best exercise for PCOS explains what the studies show.
- Ask whether any medicine for weight, insulin or cycles fits your situation, and make changes only with your clinician.
- Bring a symptom and cycle log to every appointment. A free app such as Shebalance can keep that record in one place without an account.
What the research says
The International Evidence-based PCOS Guideline 2023 is the most current international reference for assessing and managing PCOS, and it covers cardiometabolic, sleep and mental health needs alongside fertility and cycle care (Monash University guideline). It builds on the Rotterdam consensus, published in Human Reproduction in 2004, which set the diagnostic criteria that most research on PCOS still uses (Rotterdam consensus group, Human Reproduction, 2004). The World Health Organization's fact sheet estimates that 10–13% of women of reproductive age have PCOS and that up to 70% of those affected are undiagnosed (WHO PCOS fact sheet). That gap is why long term risks often go unaddressed.
The newest development is the 2026 Lancet consensus, in which Teede HJ and colleagues propose the name polyendocrine metabolic ovarian syndrome (PMOS) and a three-year transition (Teede et al., The Lancet, 2026). The consensus does not set new treatment rules, so the checks described in this article remain the practical guide.
Semaglutide's STEP 1 trial, reported by Wilding and colleagues in the New England Journal of Medicine in 2021, is the reference for how much weight semaglutide reduced in adults with overweight or obesity, but it did not include people with PCOS (Wilding et al., New England Journal of Medicine, 2021). The strength of evidence differs by risk. Diabetes risk and blood fat changes have the most consistent evidence. Sleep apnea and endometrial findings are recognized in the 2023 guideline, though they rest on a smaller body of studies. Long-term outcome trials that look specifically at heart events and cancer in PCOS are limited, so readers should treat any single study with care.
When to see a doctor
Get urgent care if you notice
- Bleeding after menopause, or bleeding that is much heavier than usual, lasts unusually long, or happens between periods.
- Severe pelvic pain that is sudden, persistent or getting worse.
- Chest pain, pressure or tightness, or pain spreading to the arm, jaw or back.
- Sudden weakness or numbness on one side of the body, trouble speaking, or sudden loss of vision.
- Signs of a blood clot, such as one leg that is swollen, painful, warm or red, or sudden shortness of breath.
- Very high thirst, frequent urination, confusion or unusual drowsiness, which can signal dangerously high blood sugar.
- Thoughts of suicide or self-harm. In the U.S., call or text 988; in the UK, call Samaritans on 116 123; anywhere else, call your local emergency number.
Regional notes
United States: The CDC's PCOS and diabetes guidance, the National Institute of Child Health and Human Development's PCOS overview and the Office on Women's Health all describe the diabetes and metabolic side of PCOS (NICHD, PCOS; Office on Women's Health, PCOS). The American College of Obstetricians and Gynecologists publishes patient guidance on abnormal bleeding. The U.S. Food and Drug Administration (FDA) approves medicine labels, so check the official prescribing information for any drug you are considering.
United Kingdom: The National Health Service (NHS) PCOS overview explains the diagnostic checks and the metabolic follow-up you can ask your GP (general practitioner) about (NHS, PCOS). NHS services set their own follow-up pathways, so ask your GP what is available locally.
European Union and Australia: Health services in these regions set their own screening and follow-up schedules through national and regional systems. Medicines are regulated by national agencies, such as the European Medicines Agency in the EU and the Therapeutic Goods Administration (TGA) in Australia, so check the status of any treatment with your local regulator and your clinician.
South Asia and the Middle East: Diabetes risk runs higher in many South Asian and Middle Eastern populations, so local clinicians may recommend blood sugar screening earlier for women with PCOS. Ask your national health ministry or your local primary care service which screening pathway applies to you.
Frequently asked questions
Does PCOS always lead to type 2 diabetes?
No. PCOS raises the chance of developing type 2 diabetes, but many people with PCOS never develop it. The CDC describes the link as an association, and insulin resistance is the main reason for it. Regular blood sugar checks let your clinician spot changes early, when lifestyle steps are most effective. The 2023 guideline recommends a test at diagnosis, repeated every one to three years based on your results and risk factors.
Can a person with PCOS who is lean still have long term risks?
Yes. Insulin resistance and blood fat changes can occur in lean people with PCOS, so a normal body weight does not rule out metabolic risk. The International Evidence-based PCOS Guideline 2023 recommends assessing cardiometabolic health in people with PCOS, not only in those who carry excess weight. Ask for blood pressure, blood sugar and lipid checks regardless of your weight, and share your family history of diabetes or heart disease.
Does PCOS cause sleep apnea?
Whether PCOS directly causes sleep apnea is not established, but the 2023 guideline states that sleep apnea is significantly more common in people with PCOS, independent of body weight, and excess weight raises the risk further. Snoring, breathing pauses and daytime sleepiness are the signs to report. A sleep study confirms the diagnosis, and treatment can include weight and lifestyle changes or a CPAP device.
Can PCOS lead to endometrial cancer?
PCOS can lead to endometrial hyperplasia when ovulation is rare, because estrogen acts on the uterine lining without progesterone to balance it. In some cases, hyperplasia can progress to endometrial cancer. Not every thickened lining becomes cancer, and treatment can restore a healthy lining. Bleeding that is heavier, longer, unusual or after menopause needs prompt assessment, so do not wait for your next routine visit if you notice it.
How often should blood sugar be checked with PCOS?
The International Evidence-based PCOS Guideline 2023 recommends checking blood sugar at diagnosis and then every one to three years, depending on your other risk factors, with the OGTT as the most accurate test. Keep a dated record of each result, and ask for a clear plan for the next check.
Can weight loss alone reduce long term PCOS risks?
Weight loss can improve insulin sensitivity, blood pressure and blood fats for many people, and it is a central part of lifestyle care. It is not the only lever, though. Some people have risks even at a healthy weight, and others need medicine as well. Weight management should be gradual and supported, without weight shaming, and it works best alongside activity, sleep and a clinician's review of your individual risks.
Does the PMOS name change mean PCOS is a different condition?
No. The 2026 Lancet consensus proposes renaming PCOS to polyendocrine metabolic ovarian syndrome (PMOS) and describes a three-year transition. The condition is the same. The new name reflects the wider hormonal and metabolic picture that matters for long term health. Until guidelines formally adopt the new name, your clinician will likely continue to use PCOS in records, so you can use either term when you talk about your care.
The bottom line
PCOS long term risks are mostly metabolic. Type 2 diabetes, blood pressure and blood fat changes that raise heart risk, sleep apnea and changes to the uterine lining when ovulation is rare are the most important to know about. None of them is inevitable. Regular checks of blood sugar, blood pressure, lipids and cycle pattern let your clinician act early, and lifestyle changes remain the foundation of care. Medicines, including GLP-1 medicines, are options that clinicians weigh against your own history, and they should never be started or stopped on your own. Keeping a clear record makes every appointment more useful. Shebalance on Google Play is a free, private Android app with no account needed. It logs symptoms in one tap, shows weekly and monthly trends and creates a doctor-ready PDF for your next visit.
Medical disclaimer
This article is for education only and is not medical advice. It does not diagnose or treat any condition. Talk with a qualified clinician about your symptoms, test results and treatment options, and do not start, stop or change any medicine without their guidance. In an emergency, call your local emergency number.
References
- World Health Organization. Polycystic ovary syndrome fact sheet. https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome
- Centers for Disease Control and Prevention. Diabetes and polycystic ovary syndrome (PCOS). https://www.cdc.gov/diabetes/risk-factors/pcos-polycystic-ovary-syndrome.html
- Teede HJ, et al. International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome, 2023. Monash University. https://www.monash.edu/medicine/mchri/pcos/guideline. Recommendations published as: Teede HJ, Tay CT, Laven J, et al. Human Reproduction, 2023;38(9):1655-1679. https://doi.org/10.1093/humrep/dead156
- Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Human Reproduction, 2004. https://doi.org/10.1093/humrep/deh098
- Teede HJ, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet, 2026. https://doi.org/10.1016/S0140-6736(26)00717-8
- National Health Service (UK). Polycystic ovary syndrome (PCOS). https://www.nhs.uk/conditions/polycystic-ovary-syndrome-pcos/
- American College of Obstetricians and Gynecologists. Patient FAQs. https://www.acog.org/womens-health/faqs
- American Heart Association. Life's Essential 8. https://www.heart.org/en/healthy-living/healthy-lifestyle/lifes-essential-8
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1 trial). New England Journal of Medicine, 2021;384(11):989-1002. https://doi.org/10.1056/NEJMoa2032183
- Office on Women's Health (U.S.). Polycystic ovary syndrome. https://www.womenshealth.gov/a-z-topics/polycystic-ovary-syndrome
- National Institute of Child Health and Human Development (U.S.). PCOS. https://www.nichd.nih.gov/health/topics/pcos
- Wegovy (semaglutide) U.S. prescribing information. Novo Nordisk. Section 8.3. [VERIFY LINK]
- Zepbound (tirzepatide) U.S. prescribing information. Eli Lilly. Section 7.2. [VERIFY LINK]
Shebalance
Track PCOS and menopause symptoms privately: one-tap logs, weekly trends and a doctor-ready PDF. Free, no account.